VTYX News and Press, Ventyx Biosciences Inc. From 03/08/24

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Ventyx To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - March 8, 2024) - Faruqi & Faruqi, LLP, a leading national sec...

2024-03-07 09:09:27 ET CERo Therapeutics ( CERO ) +625% after announces publication of preclinical research supporting the use of its clinical candidate CER-1236 to treat AML patients . Lytus Technologies ( LYT ) +210% after enters $326 billion data center market...

2024-03-07 08:33:08 ET More on Ventyx Biosciences Ventyx: Too Risky Right Now After Some Poor Data Microcap ZyVersa up 71% on study supporting new way to fight obesity Ventyx surges as Piper highlights potential against obesity Seeking Alpha’s Quant Ra...

SAN DIEGO, March 07, 2024 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a range of inflammatory diseases with significant unmet medical need, announced today t...

2024-03-06 11:25:10 ET Over the past 3 months the biotech space is +30.4% and has only been outperformed by semiconductors, computer processing hardware and the computer peripherals industries. Additionally, the biotech sector is +13.6% in 2024, outdoing all of the major market aver...

NEW YORK, March 04, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California on behalf of all persons and entities who purchased or otherwise acquired: (a) Ven...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Ventyx To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - March 4, 2024) - Faruqi & Faruqi, LLP, a leading national sec...

2024-03-04 09:30:00 ET March 4, 2024 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces today's roundup of stocks to watch in the AI (artificial intelligence) Tech and Biotech sectors. The newest tech companies are all invo...

SAN DIEGO, March 04, 2024 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today annou...

Ventyx to host virtual investor event on March 11 th to provide clinical updates on our NLRP3 portfolio and from the open-label extension of the VTX002 Phase 2 trial in ulcerative colitis Cash, cash equivalents and marketable securities of $252.2 million as of December 31, 2...